Brought to you by 
Opko Health FOPO nets $105mm
05 Apr 2011
Executive Summary
Opko Health Inc. (drugs, devices, and diagnostics for ophthalmic, infectious, and neurological diseases and cancer) netted $105mm through the public offering of 29.4mm shares (including the overallotment) at $3.75 each.
Deal Industry
- In Vitro Diagnostics
-
Pharmaceuticals
- Vaccines
-
Medical Devices
- Surgical Equipment & Devices
-
Diagnostic Imaging Equipment & Supplies
- Ultrasound
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
- Antisense, Oligonucleotides
- Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- FOPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Opko Health FOPO nets $105mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice